Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 16;23(6):3222.
doi: 10.3390/ijms23063222.

HNF1A Mutations and Beta Cell Dysfunction in Diabetes

Affiliations
Review

HNF1A Mutations and Beta Cell Dysfunction in Diabetes

Yasutaka Miyachi et al. Int J Mol Sci. .

Abstract

Understanding the genetic factors of diabetes is essential for addressing the global increase in type 2 diabetes. HNF1A mutations cause a monogenic form of diabetes called maturity-onset diabetes of the young (MODY), and HNF1A single-nucleotide polymorphisms are associated with the development of type 2 diabetes. Numerous studies have been conducted, mainly using genetically modified mice, to explore the molecular basis for the development of diabetes caused by HNF1A mutations, and to reveal the roles of HNF1A in multiple organs, including insulin secretion from pancreatic beta cells, lipid metabolism and protein synthesis in the liver, and urinary glucose reabsorption in the kidneys. Recent studies using human stem cells that mimic MODY have provided new insights into beta cell dysfunction. In this article, we discuss the involvement of HNF1A in beta cell dysfunction by reviewing previous studies using genetically modified mice and recent findings in human stem cell-derived beta cells.

Keywords: GWAS; HNF1A; MODY; MODY3; beta cell dysfunction; dedifferentiation; diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Physiological role of HNF1A in the liver, pancreas, kidneys, and intestine.
Figure 2
Figure 2
Schematic representation of beta cell dysfunction caused by HNF1A mutations.

Similar articles

Cited by

References

    1. Chatterjee S., Khunti K., Davies M.J. Type 2 diabetes. Lancet. 2017;389:2239–2251. doi: 10.1016/S0140-6736(17)30058-2. - DOI - PubMed
    1. Pihoker C., Gilliam L.K., Ellard S., Dabelea D., Davis C., Dolan L.M., Greenbaum C.J., Imperatore G., Lawrence J.M., Marcovina S.M., et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: Results from the SEARCH for Diabetes in Youth. J. Clin. Endocrinol. Metab. 2013;98:4055–4062. doi: 10.1210/jc.2013-1279. - DOI - PMC - PubMed
    1. Shepherd M., Shields B., Hammersley S., Hudson M., McDonald T.J., Colclough K., Oram R.A., Knight B., Hyde C., Cox J., et al. Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes. Diabetes Care. 2016;39:1879–1888. doi: 10.2337/dc16-0645. - DOI - PMC - PubMed
    1. Urakami T. Maturity-onset diabetes of the young (MODY): Current perspectives on diagnosis and treatment. Diabetes Metab. Syndr. Obes. 2019;12:1047–1056. doi: 10.2147/DMSO.S179793. - DOI - PMC - PubMed
    1. Bartolome A. Stem Cell-Derived beta Cells: A Versatile Research Platform to Interrogate the Genetic Basis of beta Cell Dysfunction. Int. J. Mol. Sci. 2022;23:501. doi: 10.3390/ijms23010501. - DOI - PMC - PubMed

Supplementary concepts